Pertussis Vaccine: the Past, the Present and the Future
5 Angebote vergleichen

Lieferung aus: Österreich, zzgl. Versandkosten.
Pertussis Vaccine: the Past, the Present and the Future The inception of the whole cell pertussis vaccine wP saw global reduction in reported cases, mortality and morbidity burden to the disease. But, in the late 90s, wP was replaced with acellular pertussis vaccine (aP) in most countries due to safety reasons. In recent years however, the annual reported cases of pertussis globally have increase greatly even among highly vaccinated groups, 1; 2. This nurtures concerns about the level of protection aP bestows on the vaccinated individuals, 2. The aim of this current mini review is therefore to assess some recent reports and developments on the matter, evaluate how alarming the situation is by comparing the present to the past and the recommendations for roadmap into the future. 27.12.2018, Taschenbuch.

Lieferung aus: Deutschland, Versandkostenfrei.
Pertussis Vaccine: the Past, the Present and the Future: The inception of the whole cell pertussis vaccine wP saw global reduction in reported cases, mortality and morbidity burden to the disease. But, in the late 90s, wP was replaced with acellular pertussis vaccine (aP) in most countries due to safety reasons. In recent years however, the annual reported cases of pertussis globally have increase greatly even among highly vaccinated groups, 1 2. This nurtures concerns about the level of protection aP bestows on the vaccinated individuals, 2. The aim of this current mini review is therefore to assess some recent reports and developments on the matter, evaluate how alarming the situation is by comparing the present to the past and the recommendations for roadmap into the future. Englisch, Taschenbuch.

Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Lieferzeit: 11 Tage, zzgl. Versandkosten.
The inception of the whole cell pertussis vaccine wP saw global reduction in reported cases, mortality and morbidity burden to the disease. But, in the late 90s, wP was replaced with acellular pertussis vaccine (aP) in most countries due to safety reasons. In recent years however, the annual reported cases of pertussis globally have increase greatly even among highly vaccinated groups, 1, 2. This nurtures concerns about the level of protection aP bestows on the vaccinated individuals, 2. The aim of this current mini review is therefore to assess some recent reports and developments on the matter, evaluate how alarming the situation is by comparing the present to the past and the recommendations for roadmap into the future.